Nuwellis closes $6.0M registered public offering of common stock and warrants

Nuwellis completed a public offering generating $6.0 million in gross proceeds through the sale of common stock, pre-funded warrants, and Series C and D warrants. The offering expands the company's capital base to fund operations for its cardiorenal medical technology solutions.